Sponsored Links
| Patients With Aggressive Lymphoma Benefit From Two Targeted Therapies |
 |
 |
 |
| Medical News - Lymphoma and Leukemia | |||
|
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG). Read more: Lymphoma / Leukemia News From Medical News Today
|